Last updated: October 20, 2026
Purpose and Editorial Principles
Our pages should answer a specific question without stretching evidence beyond its scope. A branded-product guide must distinguish brand identity from generic equivalence and current inventory. A comparison must identify the correct active substances, strengths, routes and evidence limits. A purchase guide should explain legally authorized clinical and pharmacy steps without listing fabricated providers, prices or stock.
The intended audience is people researching the U.S. prescription landscape. Content is educational and is not a recommendation to start, stop or change an antimicrobial without a clinician. We avoid creating thin pages that simply rephrase another URL, and we correct misleading or outdated statements when supported evidence is available.
Evidence Hierarchy Depends on the Claim
FDA approval and Orange Book records are appropriate for U.S. product authorization and therapeutic-equivalence questions; DailyMed is valuable for formulation-specific prescribing information. CDC BV guidance and other CDC guidelines inform BV, trichomoniasis and other infection treatment contexts. The American College of Gastroenterology supplies specialty guidance for H. pylori regimens. Original clinical trials are required for claims about comparative study outcomes.
| Claim | Preferred evidence | Interpretation limit |
|---|---|---|
| FDA product approval | Drugs@FDA / Orange Book | An NDC or label alone is not approval |
| Drug instructions and warnings | Correct product prescribing information / DailyMed | Another route or brand may differ |
| BV or trichomoniasis recommendations | CDC condition-specific guidance | Not a patient-specific prescription |
| H. pylori treatment selection | ACG guideline and original label | 10-day Pylera pack ≠ 14-day optimized BQT |
| Head-to-head effectiveness | Original randomized controlled study | Only studied formulations and populations |
| Online pharmacy legitimacy | FDA BeSafeRx and state board | Search placement is not licensure |
| Cost or insurance | Specific pharmacy, insurer and current terms | No permanent national price or coverage promise |
Product Identity Before Generalizations
MetroMedX distinguishes immediate-release oral metronidazole tablets, 375 mg capsules, extended-release tablets and oral suspension. Vaginal gels are separate from rosacea creams, gels and lotions even when they show the same percentage. A description of one product must not be applied to another merely because the ingredient matches.
Branded references include Flagyl, LIKMEZ, Nuvessa, Vandazole, MetroGel, Noritate and Pylera. For example, Nuvessa 1.3% has an FDA-approved generic referencing that product; it is not a generic of 0.75% vaginal gel. A regulatory approval does not prove today’s pharmacy supply.
Guidelines and FDA Labels Can Answer Different Questions
The 2024 ACG guideline discusses fourteen days of optimized bismuth quadruple therapy in many H. pylori contexts, whereas the U.S. Pylera label describes a ten-day package used with omeprazole. The two cannot be treated as interchangeable dosing instructions.
For BV, CDC treatment options include specific oral and intravaginal metronidazole regimens; newer evidence about recurrent BV and partner treatment may require dated explanation rather than erasing earlier guideline language. We identify which document and date support a recommendation and do not make blanket personal-treatment claims.
Comparisons and Study Evidence
Direct randomized trials are preferred for comparative effectiveness when available. We identify the exact drugs, concentrations, population, endpoints, duration and limitations. When only separate studies are available, we do not declare a winner by comparing unrelated percentages.
Rosacea content distinguishes papules and pustules from persistent erythema; Mirvaso and Rhofade do not have the same symptom target as all topical metronidazole products. A clinical alternative is not an FDA-equivalent generic or authorization for pharmacist substitution.
Safety Information and Clinical Limits
Important contraindications, class warnings, interactions, pregnancy-related considerations, clindamycin vaginal product barrier-material cautions, and route errors deserve precise descriptions supported by the relevant label. We do not convert general warning text into individualized medical advice.
Statements about antibiotics should not encourage using stored courses, no-prescription sellers or unsupervised switching. Severe symptoms and adverse reactions require contact with an appropriate healthcare professional.
Pricing, Insurance and Pharmacy Claims
Cost content uses an evergreen methodology: identify the exact formulation and quantity, compare actual cash or insurance responsibility, and ask about fees and participating pharmacies. We avoid fabricated live quotes, guaranteed discount codes, pharmacy rankings and inventory assertions. A telehealth evaluation never guarantees a prescription.
For online pharmacies, we favor state board licensing checks and FDA BeSafeRx guidance. A polished website, sponsored placement or third-party referral cannot substitute for those checks.
Editorial Review Versus Medical Review
Fact checking can validate links, dates, labels and terminology, but it is not equivalent to an independent clinical review. Only completed, documented reviews may be attributed to real qualified reviewers; a general policy does not establish individual page sign-off. See Medical Review Process and Reviewer Standards.
Corrections, Updates and Disclosure
Readers can report a broken citation or a misleading statement through Contact MetroMedX. We assess the claim, appropriate primary sources and the possible need for a dated correction; submission does not guarantee a particular conclusion or reply.
The site may contain sponsored affiliate referrals, but payment relationships should be disclosed and should not determine claims about drug safety, FDA approval, regulatory status or patient outcomes. The About page describes our educational scope.